Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Pharmaceutical Design|March 2, 2017
Theoretical Studies for Dendrimer-Based Drug DeliveryMartiniano Bello, Jonathan Fragoso-Vázquez, José Correa-Basurto
International Journal of Biological Macromolecules|July 27, 2016
Energetic and conformational features linked to the monomeric and dimeric states of bovine BLGMartiniano Bello, M Jonathan Fragoso-Vázquez, José Correa Basurto
International Journal of Biological Macromolecules|February 19, 2017
Molecular recognition between pancreatic lipase and natural and synthetic inhibitorsMartiniano Bello, Lucia Basilio-Antonio, Jonathan Fragoso-Vázquez, et al.
Microbiology Spectrum|September 27, 2023
Streptomyces albidoflavus Q antifungal metabolites inhibit the ergosterol biosynthesis pathway and yeast growth in fluconazole-resistant Candida glabrata: phylogenomic and metabolomic analysesCelia Bautista-Crescencio, Arturo Casimiro-Ramos, M Jonathan Fragoso-Vázquez, et al.
Scientific Reports|March 1, 2023
PAMAM-G4 protect the N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and maintain its antiproliferative effects on MCF-7Alma Alicia Ortiz-Morales, Juan Benjamín García-Vázquez, Manuel Jonathan Fragoso-Vázquez, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2018
Oenothera rosea L´Hér. ex Ait attenuates acute colonic inflammation in TNBS-induced colitis model in rats: in vivo and in silico myeloperoxidase roleNatalia Calva-Candelaria, María Estela Meléndez-Camargo, Hortensia Montellano-Rosales, et al.
Oncotarget|March 7, 2019
Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cellsArturo Contis-Montes de Oca, Estefanía Rodarte-Valle, Martha Cecilia Rosales-Hernández, et al.
Oncotarget|October 4, 2018
N-(2'-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cellsArturo Contis-Montes de Oca, Estefanía Rodarte-Valle, Martha Cecilia Rosales-Hernández, et al.
Journal of Molecular Neuroscience : MN|November 27, 2019
Neuroprotective Effects of Apocynin and Galantamine During the Chronic Administration of Scopolamine in an Alzheimer's Disease ModelEliezer Joseph, Daniel Miguel Ángel Villalobos-Acosta, Mónica Adriana Torres-Ramos, et al.
Pharmaceuticals (Basel, Switzerland)|January 13, 2021
Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer CellsDavid Méndez-Luna, Loreley Araceli Morelos-Garnica, Juan Benjamín García-Vázquez, et al.
Pageof 2